Healthequity (Germany) Performance
| 2HE Stock | EUR 90.50 1.50 1.69% |
On a scale of 0 to 100, Healthequity holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.74, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Healthequity's returns are expected to increase less than the market. However, during the bear market, the loss of holding Healthequity is expected to be smaller as well. Please check Healthequity's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Healthequity's current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Healthequity are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Healthequity reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 328.8 M | |
| Total Cashflows From Investing Activities | -639.2 M |
Healthequity |
Healthequity Relative Risk vs. Return Landscape
If you would invest 7,100 in Healthequity on September 24, 2024 and sell it today you would earn a total of 1,950 from holding Healthequity or generate 27.46% return on investment over 90 days. Healthequity is currently producing 0.4035% returns and takes up 2.4881% volatility of returns over 90 trading days. Put another way, 22% of traded stocks are less volatile than Healthequity, and 92% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Healthequity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Healthequity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Healthequity, and traders can use it to determine the average amount a Healthequity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1622
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 2HE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.49 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Healthequity is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Healthequity by adding it to a well-diversified portfolio.
Healthequity Fundamentals Growth
Healthequity Stock prices reflect investors' perceptions of the future prospects and financial health of Healthequity, and Healthequity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Healthequity Stock performance.
| Return On Equity | -0.0313 | |||
| Return On Asset | 0.0037 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.61 B | |||
| Shares Outstanding | 84.64 M | |||
| Price To Earning | 48.79 X | |||
| Price To Book | 2.82 X | |||
| Price To Sales | 6.20 X | |||
| Revenue | 756.56 M | |||
| EBITDA | 107.02 M | |||
| Cash And Equivalents | 329.31 M | |||
| Cash Per Share | 5.25 X | |||
| Total Debt | 922.08 M | |||
| Debt To Equity | 7.50 % | |||
| Book Value Per Share | 22.25 X | |||
| Cash Flow From Operations | 141 M | |||
| Earnings Per Share | (0.66) X | |||
| Total Asset | 3.11 B | |||
About Healthequity Performance
By analyzing Healthequity's fundamental ratios, stakeholders can gain valuable insights into Healthequity's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Healthequity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Healthequity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah. HealthEquity operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1141 people.Things to note about Healthequity performance evaluation
Checking the ongoing alerts about Healthequity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Healthequity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 756.56 M. Net Loss for the year was (44.29 M) with profit before overhead, payroll, taxes, and interest of 423.71 M. | |
| Over 98.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Healthequity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Healthequity's stock is overvalued or undervalued compared to its peers.
- Examining Healthequity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Healthequity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Healthequity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Healthequity's stock. These opinions can provide insight into Healthequity's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Healthequity Stock analysis
When running Healthequity's price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |